Thermo Fisher Scientific Inc.'s Q3 results demonstrated some end-market stability, particularly in the life science market.

The fetal abnormality test measures the most common chromosomal abnormalities, including Down syndrome, via a single-tube PCR process.

Recently, Perry O. Hooper, former state representative, wrote a column in this paper with the headline, “Vance destroys Walz ...

Thermo Fisher Scientific on Wednesday raised the lower end of its annual profit forecast, tweaking it for the third time this ...

The Pan Continental Championships round-robin programme passed the halfway mark on Tuesday’s third day of competition. In the men’s A Division, after three days of competition and five round-robin ...

In its 3QFY2024 results call, Thermo Fisher highlighted that economic activity in China was muted and the company is hoping ...

Bush “firmly believed that only by working with China can the United States realize ... You’ve got time to look lots of things up. Linda Fisher, a resident of Prattville, is a novelist ...

Q3 2024 Earnings Call Transcript October 23, 2024 Thermo Fisher Scientific Inc. beats earnings expectations. Reported EPS is ...

As it has striven toward superiority in most measures of the Asian military balance, China is now ready to challenge the undersea balance of power, long dominated by the United States, a decisive ...

This article was first published by the Salish Current. With the commercial salmon season coming to an end, 2024 is shaping ...